Trade LGND stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Ligand Pharmaceuticals Incorporated (LGND) is trading at US$316.27, down 0.18% today as of Nov 12, 16:00 EST. The company has a market capitalisation of US$5.71B. Over the past 52 weeks, LGND has traded between US$175.89 and US$326.63. On Syfe you can trade LGND with $0 commission and add it to your watchlist.
| Previous close | US$316.83 |
|---|---|
| Market cap | US$5.71B |
| P/E ratio | 27.17 |
| 52-week range | US$175.89 – US$326.63 |
| Volume | 241.21K |
| Exchange | US |
Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company that involves clinical development and commercialization of high-value medicines. Its platforms, Captisol and NITRICI, offer technology with broad applicability in drug development to a large network of biopharmaceutical partners, including the largest pharmaceutical manufacturers in the world. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.
Year: 1994
Ligand Pharmaceuticals Incorporated (LGND) stock is trading at US$316.27, -0.18% from the previous close of US$316.83.
The market cap for Ligand Pharmaceuticals Incorporated (LGND) stock is approximately US$5.71B.
The price-to-earnings ratio for Ligand Pharmaceuticals Incorporated (LGND) is 27.17, based on the latest reported earnings.
The 52-week high for Ligand Pharmaceuticals Incorporated (LGND) stock is US$326.63.
The 52-week low for Ligand Pharmaceuticals Incorporated (LGND) stock is US$175.89.
Ligand Pharmaceuticals Incorporated (LGND) does not currently pay a dividend.
Stay on top of LGND
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
